Model
Edge
Regeneron Pharmaceuticals, Inc.
REGN
Filing Type
10-Q
Filing Date
7/31/2025
Updated
8/1/25, 4:56 AM
Filing
10-Q
Earnings Release
Exhibits
10-Q
Q2
EX-3.1
AMENDED AND RESTATED CERTIFICATE OF INCORPORATION
EX-10.1
AMENDED AND RESTATED COLLAB. AGREEMENT BY AND BETWEEN THE REGISTRANT AND SANOFI
EX-31.1
CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A)
EX-31.2
CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A)
EX-32
CERTIFICATION OF CEO AND CFO PURSUANT TO 18 U.S.C SECTION 1350